Antibiotic resistance, and multi-drug resistance, is a major public health threat. A new study publishing in PLOS Computational Biology finds conditions where restricting certain antibiotics may increase the frequency of multiple drug resistance.
Uri Obolski and Prof. Lilach Hadany and colleagues used a mathematical model and electronic medical records data to show that drug restriction may also lead to results opposite of those desired. Restriction might facilitate the spread of resistant pathogens, due to ineffective treatment with antibiotics that have high resistance frequencies.
If bacterial spread between patients is significant, the advantages of deliberately using the restricted antibiotics can outweigh the disadvantages, and lead to fewer instances of bacteria resistant to all available drugs in the long term as well as more effective treatment in the short term. These results have important implications for drug usage strategies and lead to rethinking the optimal ways of minimizing multiple drug resistance.
The study was performed by means of mathematical modeling, relying on data from the literature and from estimates of drug resistance using blood culture results of patients from Rabin Medical Center, Israel. Further clinical investigation, examining cultures of other infections and performing more clinical research will help ascertain and generalize the optimal conditions for drug restriction.
All works published in PLOS Computational Biology are Open Access, which means that all content is immediately and freely available. Use this URL in your coverage to provide readers access to the paper upon publication: http://journals.
Press-only preview: https:/
Contact: Lilach Hadany
Address: Tel Aviv University
Molecular Biology and Ecology of Plants
Tel Aviv, 69978
Citation: Obolski U, Stein GY, Hadany L (2015) Antibiotic Restriction Might Facilitate the Emergence of Multi-drug Resistance. PLoS Comput Biol 11(6):e1004340. doi:10.1371/journal.pcbi.1004340
Funding: This research has been supported in part by the Israeli Science Foundation 1568/13 (LH), and by a fellowship from the Manna Program in Food Safety and Security (UO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
About PLOS Computational Biology
PLOS Computational Biology features works of exceptional significance that further our understanding of living systems at all scales through the application of computational methods. All works published in PLOS Computational Biology are Open Access. All content is immediately available and subject only to the condition that the original authorship and source are properly attributed. Copyright is retained. For more information follow @PLOSCompBiol on Twitter or contact firstname.lastname@example.org.
PLOS is a nonprofit publisher and advocacy organization founded to accelerate progress in science and medicine by leading a transformation in research communication. For more information, visit http://www.